Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock

Intensive Care Med. 2013 Aug;39(8):1497-8. doi: 10.1007/s00134-013-2945-5. Epub 2013 May 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Humans
  • Hydrazones / therapeutic use*
  • Middle Aged
  • Pyridazines / therapeutic use*
  • Shock, Cardiogenic / drug therapy*
  • Shock, Cardiogenic / etiology*
  • Simendan
  • Subarachnoid Hemorrhage / complications*
  • Vasodilator Agents / therapeutic use*

Substances

  • Hydrazones
  • Pyridazines
  • Vasodilator Agents
  • Simendan